EGFR-TKI-话题@MedSci

#EGFR-TKI#

60篇内容 | 1533人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1383052, encodeId=a0ae1383052fa, content=<a href='/topic/show?id=0c8265e2b3' target=_blank style='color:#2F92EE;'>#EGFR-TKI#</a>, objectTitle=ASCO 2014：内分泌治疗/化疗+VEGFR-TKI治疗晚期乳腺癌的荟萃分析, objectType=article, longId=35696, objectId=1f4c3569670, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f4c3569670, replyNumber=0, likeNumber=36, createdTime=2014-06-02, rootId=0, userName=w984445tii, userId=6732482, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f4c3569670, moduleTitle=ASCO 2014：内分泌治疗/化疗+VEGFR-TKI治疗晚期乳腺癌的荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f4c3569670)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383051, encodeId=65d11383051e3, content=<a href='/topic/show?id=0c8265e2b3' target=_blank style='color:#2F92EE;'>#EGFR-TKI#</a>, objectTitle=ASCO 2014：T790M的异质性状态影响EGFR-TKI耐药NSCLC的化疗结果, objectType=article, longId=35691, objectId=a7ba35691f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7ba35691f6, replyNumber=0, likeNumber=45, createdTime=2014-06-02, rootId=0, userName=w984445tii, userId=6732482, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7ba35691f6, moduleTitle=ASCO 2014：T790M的异质性状态影响EGFR-TKI耐药NSCLC的化疗结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7ba35691f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383050, encodeId=da2b138305015, content=<a href='/topic/show?id=0c8265e2b3' target=_blank style='color:#2F92EE;'>#EGFR-TKI#</a>, objectTitle=ASCO 2014：EGFR-TKI治疗后柔脑膜转移的NSCLC患者脑脊液EGFR突变阳性, objectType=article, longId=35671, objectId=7538356e136, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7538356e136, replyNumber=0, likeNumber=42, createdTime=2014-06-02, rootId=0, userName=w984445tii, userId=6732482, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7538356e136, moduleTitle=ASCO 2014：EGFR-TKI治疗后柔脑膜转移的NSCLC患者脑脊液EGFR突变阳性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7538356e136)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383049, encodeId=0ca81383049bc, content=<a href='/topic/show?id=0c8265e2b3' target=_blank style='color:#2F92EE;'>#EGFR-TKI#</a>, objectTitle=晚期非小细胞肺癌EGFR-TKI失败后治疗策略, objectType=article, longId=19179, objectId=ca42191e93e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca42191e93e, replyNumber=0, likeNumber=41, createdTime=2013-05-24, rootId=0, userName=w984445tii, userId=6732482, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca42191e93e, moduleTitle=晚期非小细胞肺癌EGFR-TKI失败后治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca42191e93e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383048, encodeId=35991383048c4, content=<a href='/topic/show?id=0c8265e2b3' target=_blank style='color:#2F92EE;'>#EGFR-TKI#</a>, objectTitle=克服肺癌EGFR-TKI耐药的新方法, objectType=article, longId=3782, objectId=d35d3e8239, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d35d3e8239, replyNumber=0, likeNumber=43, createdTime=2012-01-27, rootId=0, userName=w984445tii, userId=6732482, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d35d3e8239, moduleTitle=克服肺癌EGFR-TKI耐药的新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d35d3e8239)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383047, encodeId=4a33138304e5b, content=<a href='/topic/show?id=0c8265e2b3' target=_blank style='color:#2F92EE;'>#EGFR-TKI#</a>, objectTitle=王洁：克服EGFR-TKI耐药的新方法, objectType=article, longId=3196, objectId=e919319619, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e919319619, replyNumber=0, likeNumber=35, createdTime=2011-10-17, rootId=0, userName=w984445tii, userId=6732482, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e919319619, moduleTitle=王洁：克服EGFR-TKI耐药的新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e919319619)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EGFR-TKI

2020-05-29

w984445tii (审核中...)

前往app查看评论内容

#EGFR-TKI#

ASCO 2014：内分泌治疗/化疗+VEGFR-TKI治疗晚期乳腺癌的荟萃分析

2014-06-02

w984445tii (审核中...)

前往app查看评论内容

#EGFR-TKI#

ASCO 2014：T790M的异质性状态影响EGFR-TKI耐药NSCLC的化疗结果

2014-06-02

w984445tii (审核中...)

前往app查看评论内容

#EGFR-TKI#

ASCO 2014：EGFR-TKI治疗后柔脑膜转移的NSCLC患者脑脊液EGFR突变阳性

2014-06-02

w984445tii (审核中...)

前往app查看评论内容

#EGFR-TKI#

晚期非小细胞肺癌EGFR-TKI失败后治疗策略

2013-05-24

w984445tii (审核中...)

前往app查看评论内容

#EGFR-TKI#

克服肺癌EGFR-TKI耐药的新方法

2012-01-27

w984445tii (审核中...)

前往app查看评论内容

#EGFR-TKI#

王洁：克服EGFR-TKI耐药的新方法

2011-10-17

科室
- - 订阅+
  - 更多科室
工具
服务